Can a Breath Test Detect Mesothelioma? It’s Too Soon to Tell.
Researchers are evaluating whether a breath test can detect malignant pleural mesothelioma in patients with asbestos exposure, and early results suggest it may be possible.
All articles by Alexandra Della Pia, PharmD, MBA, BCOP
Perioperative Durvalumab Does Not Impact Surgical Outcomes in NSCLC
Perioperative durvalumab does not adversely impact surgical outcomes in patients with resectable non-small cell lung cancer, results from the AEGEAN trial suggest.
Adding Chemotherapy to Osimertinib Improves PFS in EGFR-Mutant, Advanced NSCLC
Osimertinib and chemotherapy is more effective than osimertinib alone as first-line treatment for patients with EGFR-mutant, advanced NSCLC, phase 3 data suggest.
Incidence of Lung Cancer Subtypes Varies by Region
Incidence rates of lung cancer subtypes vary across global regions, data suggest.
Adding Tislelizumab to First-Line Chemo Improves Survival in ES-SCLC
Adding tislelizumab to first-line chemotherapy improved progression-free and overall survival in patients with ES-SCLC in a phase 3 trial.
Cancer Patients With ICI-Induced Acute Pancreatitis May Require Imaging, Monitoring
Cancer patients with ICI-induced acute pancreatitis may require abdominal imaging for diagnosis and monitoring for exocrine pancreatic insufficiency.
Burden of High-Deductible Health Plans May Delay Breast Cancer Diagnosis
The cost-sharing burden of high-deductible health plans may delay breast cancer diagnosis, according to researchers.
Administrative Tasks Required to Pay for Cancer Care May Prompt Nonadherence
The burden of administrative tasks required to pay for cancer care is associated with nonadherence to care, a new study suggests.
Postoperative ctDNA Status Improves Prognostication for Colorectal Cancer
Researchers found that ctDNA testing increases the prognostic value of BRAF and microsatellite status in patients with colorectal cancer.
Prognostic Factors Associated With Severe COVID-19 in Cancer Patients
Certain factors may increase the risk of severe COVID-19 in patients with cancer, research suggests.
- Loading...
Loading...
Next post in ASCO Breakthrough 2023
Loading... 
Loading...